Web-MAP Intervention for Youth With Sickle Cell Disease (Web-MAP)
WEB MAP Intervention for Youth With Sickle Cell Disease
The proposed study will determine whether the efficacy of WebMAP cognitive behavioral therapy (CBT) treatment study generalizes to pediatric sickle cell disease (SCD), and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment from sickle cell centers will also be determined. The short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral intervention in a large population of youth with SCD. The long-term goal of this research is to develop effective, easily accessible, behavioral pain interventions for youth with SCD to reduce the long-term impact of pain on function, quality of life, and health service use in this population.
The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in reducing pain and functional impairment in youth with sickle cell disease. (Figure 1) Subjects will be randomized to either the behavioral intervention or the online patient education control group. The treatment protocol will be implemented over 8 weeks in Internet-based treatment modules. The primary study outcome is pain and functional impairment measured at baseline, immediately post-treatment, and at 3-month follow-up.
연구 개요
상세 설명
The proposed study will determine whether the efficacy of WebMAP generalizes to pediatric SCD, and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment from sickle cell centers will also be determined. The short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral intervention in a large population of youth with SCD. The long-term goal of this research is to develop effective, easily accessible, behavioral pain interventions for youth with SCD to reduce the long-term impact of pain on function, quality of life, and health service use in this population.
The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in reducing pain and functional impairment in youth with sickle cell disease. (Figure 1) Subjects will be randomized to either the behavioral intervention or the online patient education control group. The treatment protocol will be implemented over 8 weeks in Internet-based treatment modules. The primary study outcome is pain and functional impairment measured at baseline, immediately post-treatment, and at 3-month follow-up.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Connecticut
-
Hartford, Connecticut, 미국, 06106
- CCMC
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Documented sickle cell disease (verified by physician at SCD center if referred participant is a self referral)
- 11-18 years old
- Parental/patient consent and patient assent
- Internet and computer or smartphone access
- Score of >3 on the SCPBI-Y
Exclusion Criteria:
- Primary language spoken other than English
- 11<Age≤19
- Serious comorbid chronic condition (e.g., diabetes, arthritis, cancer)
- More than 4 sessions of outpatient behavioral therapy for pain management in the 6 months prior to the time of screening
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: WEB-MAP CBT
Web-MAP Group.
Participants will have access to the full version of the web program.
They will be asked to log in to the website using their own personal computer at home, work, school, or a public library.
Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site.
The online treatment will take between 8 and 9 weeks for participants to complete.
Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation).
Adolescents and parents will be asked to complete a total of 8 modules each.
|
Web-MAP Group: Participants will have access to the full version of the web program.
They will be asked to log in to the website using their own personal computer at home, work, school, or a public library.
Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site.
The online treatment will take between 8 and 9 weeks for participants to complete.
Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation).
Adolescents and parents will be asked to complete a total of 8 modules each.
|
|
활성 비교기: WEB-MAP Educational Control Group
OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage.
This group will serve as an attention control condition.
Children will continue with the standard medical care that has been prescribed for their pain problem.
Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments.
This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.
|
OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage.
This group will serve as an attention control condition.
Children will continue with the standard medical care that has been prescribed for their pain problem.
Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments.
This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Efficacy in pain reduction
기간: 6 months
|
We will compare pain intensity (pain scores), pain burden (Sickle Cell Pain Burden Interview), activity limitations (Child Activity Limitations Interview), quality of life (PedsQL), and health service use, and their corresponding changes from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study).
We will used a paired sample t-test.
|
6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Efficacy of reducing depressive symptoms
기간: 6 months
|
We will compare changes changes in depressive symptoms using the Centers for Epidemiological Study Depression scale from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study).
We will used a paired sample t-test.
|
6 months
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Feasibility of WEB-MAP program
기간: 6 months
|
We will conduct interviews with participants of the study using a script to start a dialogue on how user friendly their interface is, perceived difficulties or barriers, improvements to make, and general overall feedback to modify the program.
|
6 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: William T Zempsky, MD, MPH, Connecticut Children's Medical Center
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
겸상 적혈구 질환에 대한 임상 시험
-
Sandy SrinivasGlaxoSmithKline완전한방광암 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 절제 가능한 암(방광절제술 전) | 방광(Urothelial, Transitional Cell) 암 표재성(비침습성) | 방광(Urothelial, Transitional Cell) 암 전이성 또는 절제 불가능미국
-
Ain Shams University완전한방광(Urothelial, Transitional Cell) 암 표재성(비침습성) | Transurethral Resection of Bladder Tumor이집트
-
Fondazione Policlinico Universitario Agostino Gemelli...모병상부 요로상피암 | 방광(Urothelial, Transitional Cell) 암 전이성 또는 절제 불가능이탈리아
-
L2 Bio, LLCFDAMap; Akan Biosciences, Inc.아직 모집하지 않음Crohn & amp;#39; s | Crohn & amp;#39; s Disease (CD)
-
Ankara UniversityFondazione IRCCS Istituto Nazionale dei Tumori, Milano아직 모집하지 않음방광(Urothelial, Transitional Cell) 암 전이성 또는 절제 불가능
-
Stanford UniversityNational Institutes of Health (NIH)빼는방광암 | 피부암 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 절제 가능한 암(방광절제술 전)미국
-
UNC Lineberger Comprehensive Cancer CenterFogarty International Center of the National Institute of Health모집하지 않고 적극적으로
-
Relmada Therapeutics, Inc.빼는요로상피암 방광 | 비뇨기과 암 | 요로상피암 재발성 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 암 표재성(비침습성)
-
Vanderbilt University Medical CenterTakeda Pharmaceuticals U.S.A., Inc.모집하지 않고 적극적으로염증성 장질환(IBD) | 궤양성 대장염(UC) | Crohn & amp;#39; s Disease (CD)미국
WEB-MAP CBT에 대한 임상 시험
-
Seattle Children's HospitalUniversity of Virginia모집하지 않고 적극적으로
-
Medical Therapy SolutionsArcher Research종료됨
-
University of South FloridaChildren's Board of Hillsborough County모병
-
University Hospital, MontpellierUniversity Hospital, Bordeaux완전한
-
Medical Therapy SolutionsArcher Research빼는